SEC Tracker
Get the app

BridgeBio Pharma BBIO

Kumar Haldea Revocable Trust U/A DTD 12/19/2018 (Director) plans to sell 120,000 BBIO shares, about $8.9M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Apr 9, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Conversion Management Incentive Units
  4. 10b5-1 plan adopted: Mar 31, 2025

All of Kumar Haldea Revocable Trust U/A DTD 12/19/2018's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 13,973 shares at $66.65 on May 8, 2026 · Form 4
  • Sold 13,974 shares at $66.65 on May 8, 2026 · Form 4
  • Sold 5,076 shares at $67.35 on May 8, 2026 · Form 4
  • Sold 6,725 shares at $68.3 on May 21, 2026 · Form 4
  • Sold 5,072 shares at $69.22 on May 21, 2026 · Form 4
  • Sold 11,250 shares at $70.48 on May 21, 2026 · Form 4
  • Sold 800 shares at $70.92 on May 21, 2026 · Form 4
  • Sold 2,200 shares at $65.72 on Jun 4, 2026 · Form 4
  • Sold 1,429 shares at $66.72 on Jun 4, 2026 · Form 4
  • Sold 15,921 shares at $67.74 on Jun 4, 2026 · Form 4
  • Sold 450 shares at $68.27 on Jun 4, 2026 · Form 4
  • Sold 2,200 shares at $65.72 on Jun 4, 2026 · Form 4
  • Sold 1,429 shares at $66.72 on Jun 4, 2026 · Form 4
  • Sold 15,921 shares at $67.74 on Jun 4, 2026 · Form 4
  • Sold 450 shares at $68.27 on Jun 4, 2026 · Form 4
  • Sold 7,147 shares at $67.2 on Jun 5, 2026 · Form 4
  • Sold 8,437 shares at $67.88 on Jun 5, 2026 · Form 4
  • Sold 4,416 shares at $68.96 on Jun 5, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when BridgeBio Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025
  3. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  4. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  5. Repligen RGEN public float $6.0B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.